6 unknown. 6 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 6 |
| Phase 1 | 2 | Unknown 2 |
Follow Supranuclear Palsy, Progressive: new trials by email Literature Review of Supranuclear Palsy, Progressive trials Research Report on Supranuclear Palsy, Progressive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY RT001, Placebo - Progressive Supranuclear Palsy | Phase 2 | Unknown | Biojiva LLC | 40 | 2021-06-23 | 2021-06-25 |
| Rho Kinase (ROCK) Inhibitor in Tauopathies - 1 Fasudil - Progressive Supranuclear Palsy, Corticobasal Syndrome | Phase 2 | Unknown | Woolsey Pharmaceuticals | 15 | 2021-01-22 | 2022-06-03 |
| Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks Tolfenamic Acid, Placebos - Progressive Supranuclear Palsy | Phase 1 / Phase 2 | Unknown | NeuroTau, Inc. | 24 | 2021-01-01 | 2020-02-05 |
| Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism stem cell therapy - Progressive Supranuclear Palsy | Phase 1 / Phase 2 | Unknown | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 25 | 2012-12-01 | 2013-04-04 |
| Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy rivastigmine - Progressive Supranuclear Palsy, Dementia | Phase 2 | Unknown | University Hospital Tuebingen | 20 | 2008-02-01 | 2008-02-18 |
| Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy donepezil - Supranuclear Palsy, Progressive | Phase 2 | Unknown | Groupe Hospitalier Pitie-Salpetriere | 16 | 2007-09-14 |
Corticobasal Degeneration (1) · Dementia (1)
Basal Ganglia Diseases (6) · Brain Diseases (6) · Central Nervous System Diseases (6) · Cranial Nerve Diseases (6) · Eye Diseases (6) · Movement Disorders (6) · Nervous System Diseases (6) · Neurodegenerative Diseases (6) · Neurologic Manifestations (6) · Ocular Motility Disorders (6) · Ophthalmoplegia (6) · Paralysis (6) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Tauopathies (6)
Donepezil (1) · RT001 (1) · Rivastigmine (1) · Safflower Oil (1) · fasudil (1) · tolfenamic acid (1)
Biojiva LLC (1) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1) · Groupe Hospitalier Pitie-Salpetriere (1) · NeuroTau, Inc. (1) · University Hospital Tuebingen (1) · Woolsey Pharmaceuticals (1)
Germany (2) · United States (2) · France (1) · Italy (1)
Bertrand Gaymard, MD, PhD (1) · Daniela Berg, Doctor (1) · Marwan Sabbagh, MD (1) · Nasser Zawia, PhD (1) · Peter Ljubenkov, MD (1) · Rosaria Giordano, MD (1) · Stefan Lorenzl, MD, PhD (1)